Biodesix, Inc. (BDSX) has a consensus analyst rating of Buy, based on 7 analysts covering the stock. Of those, 6 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for BDSX is $8.67, representing a -28.6% downside from the current price of $12.14. Price targets range from a low of $3.00 to a high of $20.00.
